COMMUNIQUÉS West-GlobeNewswire
-
Lighter. Cheaper. Funner. Pub Light Is Here.
11/03/2026 -
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
11/03/2026 -
Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes
11/03/2026 -
New Surveys from Instinct Science Reveal Surprising Shifts in Veterinary Practice
11/03/2026 -
BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform
11/03/2026 -
Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds
11/03/2026 -
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
11/03/2026 -
Catheter Precision, Inc. Secures up to $88 Million in Strategic Institutional Financing Commitments to Fund Accelerated Growth
11/03/2026 -
Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
11/03/2026 -
George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea
11/03/2026 -
Commit Biologics appoints serial biotech founder as new CEO to take complement-powered immune engagers into the clinic
11/03/2026 -
Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement
11/03/2026 -
Egg Medical présente les données CRT 2026 démontrant une voie responsable vers une protection légère sans plomb et sans tablier de plomb
11/03/2026 -
Propr® Introduces Propr Paste, Completing Its Clinically Inspired System for Gentle, Long-Term Oral Health
11/03/2026 -
Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering
11/03/2026 -
Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Science, and Blood Cancer Treatment
11/03/2026 -
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
11/03/2026 -
Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Science, and Blood Cancer Treatment
11/03/2026 -
TrimX Drops Metabolism Claims Evaluated: Latest Report About TrimX Liquid Thermogenic Formula Ingredient Research & Effectiveness for Men & Women
11/03/2026
Pages